NAGE

Conviction 20HealthcareScan · Fri, Jun 26, 2026

Bullish harami

NAGE$3.41+3.02%

ResistanceSupportVol 14

Vol MA14 677.6K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Niagen Bioscience, Inc.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.niagenbioscience.com ↗

Price3.41

Change+3.02%

Gap+0.00%

Rel volume2.35×

Avg volume758.57K

Avg $ vol2.66M

SMA 203.47

SMA 503.99

SMA 2005.83

Price vs 50-14.59%

Price vs 200-41.49%

MA stackbearish

50/200 cross—

Supertrenddown · 3.84

RSI (14)42

MACD hist0.03

MACD cross—

Stoch %K / %D38 / 28

ADX (14)33

+DI / −DI13 / 22

RSI divergence—

MACD divergence—

ATR %+4.90%

ADR %4.30%

52w high14.41

52w low3.31

From 52w high-76.34%

Above 52w low+3.02%

New 52w highNo

SqueezeOn · 1d

Bollinger width12.85%

%B0.36

Donchian pos18.46%

Donchian high3.94

Donchian low3.29

AVWAP (52w high)6.83

vs AVWAP high-50.10%

AVWAP (52w low)3.38

vs AVWAP low+1.03%

OBV trendFlat

Chaikin MF (20)-0.18

Today vs 20d2.35×

Avg vol (14d)677.6K

Avg vol (20d)758.57K

Avg $ vol (20d)2.66M

Market cap—

RS 3m (vs SPY)-38.57%

RS 6m (vs SPY)-57.89%

RS line new highNo

Trend template0/8

Technical rank12.6

1 week-2.57%

1 month-10.97%

3 months-23.71%

6 months-47.62%

1 year-74.57%

YTD-45.44%

P/E15.12

P/B3.19

P/S2.03

P/FCF20.60

EPS0.2000

Div yield—

ROE21.11%

ROA15.20%

Debt/Eq0.00

Current4.61

EV/EBITDA11.77

Gross margin64.28%

Net margin13.43%

Rev growth29.95%

EPS growth103.30%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value198.73M

Revenue31.47M

Net income6.32M

Gross profit19.98M

Free cash flow12.76M

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out79.64M

Employees117

ListedTue, Jun 24, 2008

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank12.6 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NAGE

All disclosures →

No recent disclosed trades by Congress in NAGE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NAGE

No recent insider (Form 4) filings in NAGE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in NAGE

EDGAR →

No recent SEC filings on file for NAGE.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.